I address this in response to the article 'Emerging trends in neonatal intestinal disease: is it time to abandon Bell's criteria?' by Gordon et al. 1 I congratulate them on their comprehensive review of acquired neonatal intestinal disease and thank them for their flattering statements concerning our original publication.
The clinical staging system was originally devised for two purposes. The first was to help guide appropriate medical versus surgical intervention in these babies. The second was to create a reference for comparison of data from among the many centers reporting on this entity.
Presumed in the application of the staging system is the correct diagnosis of necrotizing enterocolitis. Although the pathophysiology of this disorder remains under investigation, its clinical manifestations are, in most cases of Stage II and III, well defined. The radiographic patterns of pneumatosis intestinalis and the characteristic appearance of NEC at the time of exploration allow us to distinguish NEC from the other entities mentioned. They are usually quite distinct from the clinical presentations of the other ANID's to which the authors refer. That is precisely why we included Stage I, which may or may not be early NEC.
We believe that NEC is essentially the same disease whether it be in a micro preemie or in a term infant (admittedly a rare event), and regardless of the antecedent, possibly contributory events. It is clearly distinct from the entity of spontaneous intestinal perforation, and the classification was never meant to include this disorder.
Finally, in regards to the current usefulness of the classification system, I would refer to a recent publication by Desphande et al., It is with deep respect that we write this response to Dr Bell 1 who has inspired generations of physicians to do research on acquired neonatal intestinal diseases, most notably NEC. We are also pleased to read his agreement that spontaneous intestinal perforation (SIP) and necrotizing enterocolitis (NEC) are distinct and separate disease entities. We hope that this editorial exchange will encourage others to consider how best to approach these disparate diseases and the populations they affect.
However, we find his reference to the article by Deshpande et al. 2 to be an excellent example of the limitations of Bell's criteria. This meta-analysis of probiotics illustrates the utility of Bell's criteria when applied to a largely homogenous cohort of very low birth weight (VLBW) patients. The narrow weight range of the infants reviewed in this analysis also demonstrates the most significant limitation of Bell's criteria, (the mean birth weights reported in these seven studies ranged from 1026 to 1625 g). As such, the practicing clinician quickly realizes that this population is most likely to develop NEC and is at a low risk for SIP (see Figure 1 ). The application of Bell's criteria to infants weighing below 1000 g is particularly problematicFunless separate criteria for SIP are created. Previous papers examining NEC in extremely low birth weight (ELBW) populations and using Bell's criteria have frequently mis-categorized SIP as Bell's stage IIIB.
3,4 At the other end of the spectrum of intestinal disease, the pooled cohort in the study by Deshpande is also at low risk for the etiologies associated with term NEC. Most likely the population examined represents cases of preterm NEC, perhaps with an occasional cluster of virusinitiated enterocolitis (we acknowledge this is speculative, as the
